|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/36 | (2006.01) |
| A61K 38/37 | (2013.01) | ||
| A61K 38/37 | (2006.01) | ||
| A61K 38/36 | (2013.01) | ||
| A61P 7/04 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 7/02 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 7/04 | (2018.01) |
| (11) | Number of the document | 3858375 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20216368.9 |
| Date of filing the European patent application | 2012-06-11 | |
| (97) | Date of publication of the European application | 2021-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2024-03-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161495884 P | 2011-06-10 | US | |
| 201161511901 P | 2011-07-26 | US | |
| 201161523790 P | 2011-08-15 | US |
| (72) |
Scheiflinger, Friedrich , AT
Turecek, Peter , AT
Ewenstein, Bruce , US
Wong, Wing Yen , US
Suiter, Tobias M. , DE
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |
| TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |